ELLXF - Elixinol Global Limited

Other OTC - Other OTC Delayed Price. Currency in USD
0.1762
-0.0038 (-2.08%)
At close: 2:32PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close0.1800
Open0.1850
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1600 - 0.1850
52 Week Range0.1150 - 3.2700
Volume196,040
Avg. Volume166,396
Market Cap28.97M
Beta (5Y Monthly)1.05
PE Ratio (TTM)N/A
EPS (TTM)-1.3780
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Global CBD Brand Elixinol Appoints New CEO Americas
    PR Newswire

    Global CBD Brand Elixinol Appoints New CEO Americas

    Elixinol, a global hemp derived CBD brand, announced it has named Tom Siciliano as the organization's new CEO Americas effective immediately. Siciliano is charged with leading Elixinol's refined strategy on hemp derived CBD in the Americas region.

  • Can Elixinol Global (ASX:EXL) Fund Its Growth Plans?
    Simply Wall St.

    Can Elixinol Global (ASX:EXL) Fund Its Growth Plans?

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

  • Is Elixinol Global (ASX:EXL) Using Debt Sensibly?
    Simply Wall St.

    Is Elixinol Global (ASX:EXL) Using Debt Sensibly?

    Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

  • GlobeNewswire

    Elixinol Acquires Global IP Rights for Microencapsulation Technology

    Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, is pleased to announce that it has acquired the intellectual property rights over microencapsulated technology developed by Bionova. This transaction will allow Elixinol to utilize the microencapsulated technology globally.

  • GlobeNewswire

    EXL Raises A$50 Million to Support U.S. Expansion

    Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, recently announced that its parent company Elixinol Global (EXL) has raised A$50 million through the issue of approximately 12.8 million shares at A$3.90 per share to institutional investors. Proceeds acquired will be used to further expand operations in Colorado, Elixinol’s U.S. headquarters. The rapid growth displayed here is set to amplify the company’s presence in the U.S. by increasing production facilities in Colorado by an additional ~23,000 square feet to more than double the company’s current production capacity.

  • Benzinga

    Elixinol Participates In FDA's First CBD Hearing, Says Guidance, Clarity Will Benefit 'Good Players'

    The Food and Drug Administration held its first-ever hearing on CBD Friday, and market leaders gave testimony on the state of the industry and what they hope it will look like going forward.  One participant, ...

  • OTC Markets Group Launches OTCQX Cannabis Index
    PR Newswire

    OTC Markets Group Launches OTCQX Cannabis Index

    NEW YORK , June 4, 2019 /PRNewswire/ --  OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...

  • GlobeNewswire

    Elixinol Issues a Statement Following the Public FDA Hearing in Washington, D.C. on Friday, May 31

    DENVER, June 03, 2019 -- Elixinol issued the following statement regarding the public FDA hearing in Washington, D.C. on Friday, May 31. “We support the FDA’s intentions, we.